HCD MOD D

Cards (532)

  • Crystalloids

    Salts that dissolve readily into true solutions
  • Crystalloids
    • Used to manage balance through the tonicity of the solution
    • IV solutions that contain electrolytes and other agents that mimic the body's ECF are used to replace depleted fluid and promote urine output
  • Crystalloid drug examples

    • 5% dextrose & water
    • Normal saline
    • Lactated ringers
    • 5% dextrose and ½ normal saline
  • Crystalloids
    Water with electrolytes that form a solution that can pass through semipermeable membrane
  • Colloids
    Substances such as large protein molecules that do not readily dissolve into true solutions
  • Colloids
    • Expands volume= albumin is key example
    • Expands the ECF volume through replacement of proteins, starches, or other large molecules
  • Colloid drug examples

    • Serum albumin
    • Dextran 40
  • Blood products
    • Plasma
    • Cryoprecipitate
    • RBC
    • WBC
    • Platelets
  • Tonicity
    Describes the osmolarity of a solution relative to plasma
  • Isotonic
    • A solution that has the same osmolality as bodily fluids
    • Isotonic solutions do not result in any movement across the membrane through osmosis or diffusion
  • Isotonic solutions

    • Indicated for patients with hypotensive and hypovolemic states (decreased urine output, tachycardia, decreased CVP)
    • Patients require volume expansion
  • Isotonic solution examples
    • 0.9% NS
    • Lactated Ringers
    • D5W
    • D5 0.225% NaCl
  • Hypotonic
    • Shifts fluid out of the intravascular compartment, hydrating the cells and interstitial compartment
    • Osmolarity is lower than serum osmolarity
    • Hypotonic solutions cause fluid to move into the cells
  • Hypotonic solutions
    • Indicated for patients with dehydration or hypernatremia
  • Hypotonic solution examples
    • 0.45% NaCl (NS)
    • D5 0.45% NS
    • 2.5% dextrose
  • When to use hypotonic solutions
    • If there is a need to administer water to patient
    • Cells are dehydrated
    • Maintenance fluids (not volume replacement!!!)
  • Caution: Hypotonic solutions may cause cardiovascular collapse due to decrease in vascular blood volume
  • Do not administer hypotonic solutions to clients at risk for third spacing, increased intracranial pressure (head injuries), liver disease, trauma or burn patients
  • Hypertonic
    • Draws fluid into intravascular compartment from the cells and interstitial compartment
    • Osmolarity is higher than serum osmolarity
    • Hypertonic fluids pull fluid from the cells into the vascular space
  • When to use hypertonic solutions

    • Increase intravascular fluid volume
    • Pull fluid out of other compartments
    • Treat hyponatremia
    • Hypertonic + mannitol= reduce intracranial pressure
  • Hypertonic solution examples

    • 3% sodium chloride
    • D5NS
    • D5LRS
    • D5 0.45% NaCl
    • Mannitol
  • Fluid volume overload signs and symptoms: swelling (edema), high blood pressure, shortness of breath, rapid weight gain, full, bounding pulses, ascites, crackles in the lungs
  • Fluid volume deficit signs and symptoms: altered LOC, weight loss, concentrated urine (low urine output), dry mucous membranes, weak pulse, tachycardia, fatigue, thirst
  • Cardiac Output
    1. 8 L/min
  • Cardiac Index
    2.5-4 L/min
  • Heart Rate
    60-100 BPM
  • Stroke Volume
    60-120 mL/min
  • Mean Arterial Pressure (MAP)
    • 70-90 mmHg
    • Greater than 105 mmHg indicates hypertension or vasoconstriction
  • Preload
    • Right side- CVP(RA): 2-5/6
    • Left side- wedge (PCWP/PAOP): 5-12
  • Afterload
    • (right) PVR: 150-250
    • (left) SVR: 900-1400
  • Contractility
    L side- LSWDI: 35-85
  • Pulmonary pressures

    • PAS 20-30 (systolic)
    • PAD 10 (diastolic)
  • Preload management

    1. Decreased: volume; add vasoconstrictors
    2. Increased: diuretics; vasodilators
  • Afterload management
    1. Decreased: vasoconstrictors; volume
    2. Increased: vasodilators; Ca channel blockers, beta blockers
  • Contractility management
    Decreased and increased: positive inotrope
  • Heart rate management
    1. Decreased: Ca channel blockers, beta blockers
    2. Increased: atropine
  • Clinical manifestations of low cardiac output
    • Palpitations
    • Dizziness or syncope
    • Pallor
    • Diaphoresis
    • Altered mentation
    • Hypotension
    • Angina
  • 2nd degree AV block type 1 (Wenckebach)
    Priority intervention: Nothing- watch
  • 2nd degree AV block type 2
    Priority intervention: Pacemaker
  • 3rd degree AV block
    Priority intervention: Pacemaker